Skip to content
10-Q

Quarterly Report

PARATEK PHARMACEUTICALS, INC.

0001178711-22-000006

← back to feed
Filed
May 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 30, 2022 54.48M sh
Long Term Debt Q1 2022 · Mar 31, 2022 $255.95M
Long Term Debt Q1 2022 · Dec 31, 2021 $254.43M
Current Liabilities Q1 2022 · Mar 31, 2022 $28.84M
Current Liabilities Q1 2022 · Dec 31, 2021 $31.3M
Total Liabilities Q1 2022 · Mar 31, 2022 $310.46M
Total Liabilities Q1 2022 · Dec 31, 2021 $311.66M
Current Assets Q1 2022 · Mar 31, 2022 $133.28M
Current Assets Q1 2022 · Dec 31, 2021 $152.1M
Total Assets Q1 2022 · Mar 31, 2022 $170.16M
Total Assets Q1 2022 · Dec 31, 2021 $183.87M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $80.37M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $103.45M
Shares Diluted Q1 2022 · Mar 31, 2021 46.66M sh
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$21.52M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$119.01M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$102.26M
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.39
Eps Basic Q1 2022 · Mar 31, 2021 −$0.39
Sga Expense Q1 2022 · Mar 31, 2021 $22.36M
Net Income Q1 2022 · Mar 31, 2021 −$18.35M
Operating Income Q1 2022 · Mar 31, 2021 −$14.22M
Cost Of Revenue Q1 2022 · Mar 31, 2021 $2.75M
Revenue Q1 2022 · Mar 31, 2021 $16.43M